2025 General morning session (ENDURING)
In support of improving patient care, Duke University Health System Clinical Education and Professional Development is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the health care team. The designation was based upon the quality of the educational activity and its compliance with the standards and policies of the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC).

Program Description: The Southeast Regional Transplant Summit (the "Summit") brings together leaders in the field of transplantation to share the latest scientific advances in the perioperative care of solid organ transplant patients. The Summit strives to facilitate the multidisciplinary adoption of new research results and practice guidelines in kidney, liver, lung, and pediatric multi-organ transplantation. The Summit features didactic and video-based presentations on current research as well as interactive debates and discussions of interesting and challenging case studies. Participants will engage in question-and-answer sessions and learn from transplantation experts. Afternoon organ-specific breakout sessions are available for focused learning. The Summit's enduring content is a unique program that is affordable, accessible, and tailored to meet the demands of today's busy healthcare providers.
Target Audience
Allied Health Professionals
Fellows
Medical Students
Nurses
Nurse Practitioners
Physicians
Physician Assistants
Pharmacists
Learning Objectives
- Summarizing evidence on barriers to living donation among African Americans
- Describing examples of transplant policy driven by data
- Discussing opportunities for consortia to impact transplant policy
- Discussing prevalence of mood disorders in solid organ transplant
Debra Sudan, MD - Has ineligible financial relationships to disclose: Researcher for Shire Pharmaceutical Development US Inc, NIAID, CareDx, Inc, and Paragonix
John Reynolds, MD - No ineligible financial relationships to disclose
Praise Matemavi, DO, FACS - No ineligible financial relationships to disclose
Matthew Kappus, MD - No ineligible financial relationships to disclose
Jesse Schold, PhD - Has ineligible financial relationships to disclose: Consultant for eGenesis, Inc, Sanofi, Inc, Verici Dx, and United Therapeutics, Inc.
Lisa VanWagner, MD, MSc, FAST, FAHA, FAASLD - Has ineligible financial relationships to disclose: Advisory Board Madrigal pharmaceuticals, Research (enrolling site coinvestigator) Madrigal Pharmaceuticals, Research (enrolling site coinvestigator) Akero, Research (investigator-initiated), money paid to institution, W.L. Gore & Associates
Jennifer Saullo, MD, PharmD - Has ineligible financial relationships to disclose: Author for UpToDate. Unrestricted CE grant from Melinta Therapeutics to speak at MAD-ID, Mellinta
Arthur Baker, MD, MPH - No ineligible financial relationships to disclose
Greg Brown, MD - No ineligible financial relationships to disclose
ACPE - Pharmacist
AMA PRA Category 1 Credit(s)
ANCC
IACET CEU
JA Credit - AH
Available Credit
- 3.75 ACPE - Pharmacist
- 3.75 AMA PRA Category 1 Credit(s)™
- 3.75 ANCC
- 3.75 Attendance
- 0.38 IACET CEU
- 3.75 JA Credit - AH

Facebook
X
LinkedIn
Forward